Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developments in the screening for Chlamydia trachomatis: a review.

Katrin S Kohl1, Lauri E Markowitz, Emilia H Koumans

  • 1National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.

Obstetrics and Gynecology Clinics of North America
|January 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal trends in anal HPV infection among men who have sex with men attending sexual health clinics in three United States cities, 2018-2024.

Sexually transmitted diseases·2026
Same author

Decreases in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers: HPV-IMPACT, 2008 to 2019.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Acute ischemic stroke incidence after influenza or coronavirus disease 2019 among older US adults: A cross-sectional study using electronic health records.

The Journal of international medical research·2026
Same author

Post-COVID-19 conditions identified by ICD-10-CM code in a cohort of U.S. primary care patients, 2021 - 2023.

Journal of multimorbidity and comorbidity·2026
Same author

Racial and Ethnic Differences in COVID-19 Disease Severity Among US Adults in Health Systems Participating in PCORnet®: May 2020-October 2022.

Medical care·2026
Same author

Preventable Differences in Recommended Outpatient COVID-19 Treatment Among Adults With COVID-19 in the United States.

Medical care·2026

Annual screening for Chlamydia trachomatis is recommended for all women under 25. Behavioral factors and partner treatment are key for older women and reducing reinfection. Innovative screening methods are encouraged.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Chlamydia trachomatis infections are common, often asymptomatic, and can lead to serious long-term health consequences.
  • Current screening guidelines recommend annual testing for C. trachomatis in women under 25 and selective screening for older women based on behavioral risk factors.

Purpose of the Study:

  • To review current evidence and recommendations for C. trachomatis screening programs.
  • To identify areas for improvement in screening strategies, including testing methods and settings.
  • To emphasize the importance of partner management and rescreening to reduce infection sequelae.

Main Methods:

  • Review of existing studies and guidelines on C. trachomatis screening.
  • Analysis of factors influencing screening effectiveness, including age, behavior, and testing technology.

Related Experiment Videos

  • Discussion of challenges and future research directions in C. trachomatis control.

    • Main Results:

    • Annual screening for C. trachomatis is recommended for all women aged <25.
    • Behavioral criteria (e.g., number of partners, previous infection) are important for screening women >25.
    • More frequent screening may be considered for women <20 and those recently infected.
    • Partner treatment and rescreening within 4-6 months are crucial for reducing reinfection and complications.
    • Nontraditional screening settings and urine-based nucleic acid amplification tests (NAATs) show promise for improving reach and feasibility.
    • Pooling of urine specimens can reduce costs associated with large-scale screening.

    Conclusions:

    • Screening for C. trachomatis remains essential for infection control due to its high prevalence and asymptomatic nature.
    • Enhancing screening strategies through innovative approaches, improved testing technologies (NAATs), and expanded settings is vital.
    • Effective partner management and timely rescreening are critical to minimize long-term health consequences.
    • Further research is needed to optimize screening protocols, particularly regarding cost-effectiveness of NAATs and screening in men.